Tag: Abbott

European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients CardioMEMS is a paperclip-sized sensor that can remotely flag to a patient’s clinical team the early warning signs of worsening heart failure ABBOTT PARK, Ill., May 24, 2023 /PRNewswire/ — New data presented […]

Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints

Abbott’s AVEIR™ DR i2i™ IDE study is the industry’s first prospective study on the safety and performance of the world’s first dual-chamber leadless pacemaker The study successfully met all three of its primary safety and performance endpoints Abbott’s investigational AVEIR DR leadless pacemakers have been submitted for evaluation by the […]

Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm

TactiFlex™ Ablation Catheter, Sensor Enabled™, is the world’s first ablation catheter designed with a unique flexible electrode tip and contact force sensing to treat patients with atrial fibrillation When used with Abbott’s EnSite™ X EP System, physicians have better visualization allowing for more accuracy and precision with the TactiFlex catheter, […]

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite™ X EP System with Stereotaxis’ Robotic Magnetic Navigation systems. The combination of Abbott’s leading cardiac mapping system with Stereotaxis’ advanced robotic technology brings together highly detailed real-time diagnostic information with […]

NEW LATE-BREAKING DATA REINFORCE THE BENEFITS OF ABBOTT’S TRICLIP™ DEVICE FOR PEOPLE WITH TRICUSPID VALVE DISEASE

Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves Findings from the largest real-world dataset for tricuspid repair show device reduces tricuspid regurgitation and improves quality of life ABBOTT PARK, Ill., May 17, 2023 — Abbott […]

Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People’s Heart Rhythms Long-Term

Abbott’s Assert-IQ offers the world’s longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott’s portfolio of connected health devices, the Assert-IQ ICM offers long-term monitoring and remote programming to improve connectivity to patients The device provides continuous monitoring for abnormal heart rhythms while offering tools […]

Abbott Completes Acquisition of Cardiovascular Systems, Inc.

ABBOTT PARK, Ill., April 27, 2023 /PRNewswire/ — Abbott (NYSE: ABT) today announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. The transaction provides Abbott with a complementary solution for treating vascular disease. CSI’s […]

Abbott’s Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients

Abbott’s CentriMag™ Blood Pump, previously cleared for use up to six hours, now can be used to provide longer-term life support to critically ill patients, providing doctors more time to make critical care decisions Abbott’s CentriMag™ Pre-connected Pack, which combines a blood pump and oxygenator to form a life support […]

MEDINBOX PARTNERS WITH ABBOTT TO IMPROVE CONNECTIONS AND INFORMATION SHARING BETWEEN PHYSICIANS IN ELECTROPHYSIOLOGY LABS WORLDWIDE

EnSite™ Connected Care from Abbott will integrate with Medinbox’s smart video collaboration system to provide electrophysiologists with remote, real-time audiovisual support to improve case results Abbott’s exclusive global distribution agreement in electrophysiology market consolidates Medinbox’s position as major player in live medical collaboration and hospital digitization Toulouse, France, March 27, […]

NEW DATA SHOW REMOTE MONITORING TECHNOLOGY LIKE ABBOTT’S CARDIOMEMS HELPS IMPROVE SURVIVAL IN HEART FAILURE PATIENTS

New data found treatment with remote pressure monitoring can significantly reduce mortality risk in heart failure patients CardioMEMS is a tiny implantable sensor that can remotely flag early warning signs of worsening heart failure ABBOTT PARK, Ill., March 21, 2023 — Abbott today announced new data that found monitoring patients […]